SecBot SecBot
8-K ·Filed Sep 16, 2026

XCUR

EXICURE, INC.
BEARISH
Impact 7/10
Horizonweeks Processed1mo ago SEC0001193125-26-392654
Actionable Insight ▼ Bearish

Monitor for the company's compliance plan and any reverse split or capital raise announcement within the 180-day cure period. Delisting would severely reduce liquidity and institutional ownership — watch for follow-up 8-Ks detailing the plan or a Nasdaq determination.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
XCUR ▼ -13.53% at T+20d
SHORT call ✓ call won +13.53% · α vs SPY +16.71% · entry $1.33 → $1.15
Next anchor: T+60d in 6w
Latest observation: T+27 -6.24% FF3 residual α
Entry = T+0 close
Sep 16, 2026
via day close
T+1d
+1.50%
call -1.50% · α -0.37%
$1.35
settled 6w ago
T+5d
-6.77%
call +6.77% · α +9.33%
$1.24
settled 5w ago
T+20d
-13.53%
call +13.53% · α +16.71%
$1.15
settled 13d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

Exicure, Inc. filed an 8-K with Item 3.01 disclosing a delisting notice from Nasdaq. The company received notice that it no longer complies with a Nasdaq listing standard, triggering a compliance period during which it must present a plan to regain compliance or face delisting. Delisting would severely reduce liquidity and institutional ownership, pressuring the stock.

Key Facts

  • Filed 8-K with Item 3.01 (Delisting Notice) on NASDAQ
  • Company received a delisting notice from Nasdaq for failure to comply with a listing standard
  • A compliance period is typically 180 days to regain compliance
  • Company must submit a plan to regain compliance or risk delisting
  • Delisting risk is significant; failure to regain compliance would remove the stock from Nasdaq

Financial Impact

Delisting notice — no dollar amounts disclosed in the filing; potential loss of Nasdaq listing and associated liquidity

liquidityinstitutional_ownershipstock_listing

Risk Factors

  • Actual delisting from Nasdaq if compliance is not regained
  • Severe liquidity reduction and loss of institutional ownership
  • Potential financing difficulties if delisted

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (XCUR) — Batch item 10001193125-26-392654
Document: xcur-ex99_1.htm0001193125-26-392654
Document: 0001193125-26-392654-index-headers.html0001193125-26-392654
Document: 0001193125-26-392654-index.html0001193125-26-392654
Document: 0001193125-26-392654.txt0001193125-26-392654
8-K Filing (XCUR) — Batch item 60001193125-26-392654
Document: xcur-ex99_1.htm0001193125-26-392654
Document: 0001193125-26-392654-index-headers.html0001193125-26-392654
Document: 0001193125-26-392654-index.html0001193125-26-392654
Document: 0001193125-26-392654.txt0001193125-26-392654
6 reports for XCUR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XCUR — sortable, filterable
TypeNow
Sep 16, 2026
5w ago
8-K
BEARISH ★ 7/10
$1.33 $1.15▲ +13.53%▲ +16.71%$1.09 (+18.05%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$2.08 $1.75▼ −15.87%▼ −14.84%$1.09 (−47.60%)
Jun 1, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$3.11 $1.98▼ −36.33%▼ −34.77%$1.09 (−64.95%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$3.33 $2.08▼ −37.54%▼ −36.24%$1.09 (−67.27%)
Apr 10, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$3.85 $3.38▼ −12.16%▼ −19.89%$1.09 (−71.67%)
Mar 25, 2026
30w ago
Press Release
BEARISH ★ 8/10
$4.61 $3.47▲ +24.73%▲ +35.39%$1.09 (+76.36%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 7h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026